Peritoneal B-1 cells constitute a unique B cell subset, distinguished by numerous phenotypic and functionalcharacteristics. B-1 cells are an important subset to study because they are responsible for the majority ofnon-immune serum immunoglobulin (Ig), which provides serological protection against a range ofmicroorganisms prior to adaptive immunity. B-1 cells have been implicated in the pathogenesis ofautoimmunity and malignant transformation. Notably, B-1 cells represent the cell of origin for human chroniclymphocytic leukemia (CLL). In adult animals B-1 cells are self-renewing, whereas conventional splenic B(B-2) cells are not. This suggests that the regulation of G0/GI-S phase progression differs between B-1 andB-2 cells. We have reported that dramatic functional differences exist between B-1 and B-2 cells in thesignals required for S-phase entry. B-1 cells fail to proliferate to anti-lg stimulation, which drives B-2 cells intoS phase. Conversely, B-1 cells proliferate in response to phorbol ester (PMA) and do so unusually rapidly,whereas B-2 cell proliferation requires PMA plus calcium ionophore. We have studied the cell cycle responseto PMA as a means to understand the regulation of G0/G1-S phase progression in B-1 and, more generally,all B cells. Our work has led to several key findings: (i) cyclin D3 is uniquely positioned to mediate S-phaseentry in PMA stimulated B-1 cells; (ii) PMA induces cyclin D3-cdk4 complex assembly in B-1 and B-2 cells,but complexes in the latter are inactive. Similarly,IL-4induces the assembly of inactive cyclin D3-cdk4complexes in B-2 cells; and (iii) cdk4 exhibits a distinct phosphorylation profile coincident with inhibition of itskinase activity in PMA-stimulated B-2 cells. The long term objective of this project is to understand theregulation and function of cyclin D3 (and cyclinD3-cdk4 complexes) in B-1 and B-2 cells as an entry point fordissecting important elements that govern restriction point progression and commitment to S-phase entry ofall B cells. This will be accomplished through three specific aims. 1. Elucidate the biological role of cyclin D3in peritoneal B-1 cells; 2. Map the phosphorylation sites on cdk4 in B-2 and B-1 cells; and 3. Elucidate thebiological role and regulation of individual phosphoacceptor sites in cdk4. The information developed fromthis project will elucidate novel principles that govern the regulation of G0/GI-to-S progression in B cells andwill be of general applicability to the regulation of cell cycle progression in all mammalian cell types.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI060896-06
Application #
7658498
Study Section
Special Emphasis Panel (ZAI1-KLW-I (M1))
Project Start
2008-05-01
Project End
2009-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
6
Fiscal Year
2008
Total Cost
$373,516
Indirect Cost
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030
Zhong, Xuemei; Rothstein, Thomas L (2011) L2pB1: a new player in autoimmunity. Mol Immunol 48:1292-300
Gumina, Maria R; Xu, Chenjia; Chiles, Thomas C (2010) Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E. Cell Cycle 9:820-8
Kaku, H; Rothstein, T L (2010) Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter. Genes Immun 11:55-66
Holodick, Nichol E; Tumang, Joseph R; Rothstein, Thomas L (2010) Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur J Immunol 40:3007-16
Holodick, Nichol E; Tumang, Joseph R; Rothstein, Thomas L (2009) Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. Mol Immunol 46:3029-36
Repetny, Karen J; Zhong, Xuemei; Holodick, Nichol E et al. (2009) Binding of LBP-1a to specific immunoglobulin switch regions in vivo correlates with specific repression of class switch recombination. Eur J Immunol 39:1387-94
Zhong, Xuemei; Lau, Stanley; Bai, Chunyan et al. (2009) A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum 60:3734-43
Holodick, Nichol E; Repetny, Karen; Zhong, Xuemei et al. (2009) Adult BM generates CD5+ B1 cells containing abundant N-region additions. Eur J Immunol 39:2383-94
Dufort, Fay J; Bleiman, Blair F; Gumina, Maria R et al. (2007) Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol 179:4953-7
Nikolajczyk, Barbara S; Sardi, Sylvia H; Tumang, Joseph R et al. (2007) Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure. Mol Immunol 44:3407-15

Showing the most recent 10 out of 20 publications